AUA 2017: Transrectal prostate biopsy after prophylatic preparation of the rectum with povidone-iodine- A prospective randomized trial

Boston, MA ( Dr. Jose Cdilhe, Universidade do Minho, presented a simple yet time tested solution to help lower infection rates in Transrectal ultrasound (TRUS) guided prostate biopsy that can lead to urinary tract infections in up to 11% and sepsis in up to 2% of patients. He and his team evaluated whether an original way to apply peri-procedure povidone-iodine rectal preparation prior to TRUS-guided prostate needle biopsy can reduce infectious complications.

Between January/2014 and September/2016, 94 men in private office were prospectively randomized to rectal cleansing (an original transrectal prostate massage for about half a minute with 2.5ml of betadine 100 mg/ml) (47) or no cleansing (47) before TRUS guided prostate biopsy with periprostatic local injection of lidocaine. All of the patients received prophylactic antibiotics: levofloxacine 500mg PO for 7 days, beginning the day before procedure. Patients completed a telephone interview 4 days after undergoing the biopsy and went to doctor office 2 weeks after biopsy. The primary end point was the rate of infectious complications, a composite end point of 1 or more of 1) fever greater than 38.0C, 2) urinary tract infection or 3) sepsis (standardized definition).

Infectious complications developed in 6 cases (11%) in the non-rectal preparation group: one patient had sepsis (2%) and five had fever without sepsis. In the povidone-iodine rectal preparation group we had no infectious complication (0.0%).

Of the 94 men who underwent TRUS guided biopsy, 45 (47.9%) were diagnosed with prostate cancer and 3 (3.2%) had Atypical Small Acinar Proliferation (ASAP) in the result. The hospital admission rate for urological complications within 30 days of the procedure was 1%, and only for infection related reasons (sepsis).

Given the recent rise in infection rates resulting from transrectal ultrasound (TRUS) biopsies and other transrectal procedures, the administration of quinolone-based prophylactic antibiotics and the simple use of 2.5 ml of povidone-iodine solution in a transrectal prostate massage for about half a minute provided an excellent protocol for reducing infective complications of TRUS-guided prostate biopsy. The simplicity of this method and cost effectiveness of betadine100 mg/ml is noteworthy, with statistically significant relative risk reduction of infectious complications in this study. While a member of the panel pointed out that use of 2.5 ml of povidone-iodine solution in a transrectal prostate massage for about half minute is not new, the author pointed out that this step, along with quinolone-based prophylactic antibiotics, is not typically used but could easily be added to a the pre-biopsy protocol to help lower infection rates. While the study shows promising results, randomized study on a much larger population base would be warranted to show conclusive results.

Presented By: Dr. Jose Cdilhe, Universidade do Minho

Authors: José Cadilhe*, Viana do Castelo, Portugal

Written By: Henry Oat, Clinical Trial - Patient Coordinator at Desert Medical Imaging, Prostate Cancer Support Group Leader, Patient-Advocate and John Fortin, Retired Healthcare Actuary, Fellow in the Society of Actuaries, and Patient-Advocate. Both John and Henry are prostate cancer survivors.

at the 2017 AUA Annual Meeting - May 12 - 16, 2017 – Boston, Massachusetts, USA

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.